3/18
08:03 am
aldx
Aldeyra Therapeutics (ALDX) had its "neutral" rating reaffirmed by HC Wainwright. They now have a $2.00 price target on the stock, down from $10.00.
High
Report
Aldeyra Therapeutics (ALDX) had its "neutral" rating reaffirmed by HC Wainwright. They now have a $2.00 price target on the stock, down from $10.00.
3/18
06:06 am
aldx
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
High
Report
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
3/18
06:06 am
aldx
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
High
Report
Aldeyra downgraded to Neutral from Buy at H.C. Wainwright
3/17
06:07 pm
aldx
Aldeyra Therapeutics (ALDX) had its "buy" rating reaffirmed by BTIG Research.
High
Report
Aldeyra Therapeutics (ALDX) had its "buy" rating reaffirmed by BTIG Research.